Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

NSCI (LON) 38.00 GBX

Result of AGM

May 20, 2014

-

News, RNS Announcements

RNS Number : 6276H

NetScientific PLC

20 May 2014

NetScientific plc

Result of AGM

NetScientific is pleased to announce that at its Annual General Meeting held earlier today all resolutions proposed in the Notice of the Meeting were duly passed.

For further information, please contact:

Liberum (Nomad & Broker)

Chris Bowman / Christopher Britton / Thomas Bective

Tel: 020 3100 2000

Bell Pottinger

Daniel de Belder

Tel: 020 7861 3232

Company website:www.netscientific.net

ABOUT NETSCIENTIFIC

NetScientific is a healthcare and life sciences company with global reach that funds and develops technologies that offer transformative benefits to peoples’ lives and society through improved diagnosis, prognosis and treatment. The group is primarily focused on identifying and developing cutting edge technologies with applications in several: (i) cardiovascular; (ii) liver; (iii) cancer; (iv) metabolic; and (v) digital health.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGAMMFTMBTTBLI

NetScientific plc

6 Bevis Marks
1st floor, Bury Court
London
EC3A 7BA

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

copyright

Result of AGM - NetScientific